Selective modulation by PARP-1 of HIF-1α-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions

[Background] The adaptation to hypoxia is mainly controlled by the HIF transcription factors. Increased expression/activity of HIF-1α correlates with poor prognosis in cancer patients. PARP-1 inhibitors are used in the clinic to treat BRCAness breast/ovarian cancer and have been shown to regulate th...

Descripción completa

Detalles Bibliográficos
Autores: Martí , Juan Manuel, García-Díaz, Ángel, Delgado-Bellido, Daniel, O’Valle, Francisco, González-Flores, Ariannys, Carlevaris, Onintza, Rodríguez-Vargas, José Manuel, Amé, Jean Christophe, Dantzer, Françoise, King, George L., Dziedzic, Klaudia, Berra, Edurne, Álava, Enrique de, Amaral, Ana Teresa, Hammond, Ester M., Oliver, Francisco Javier
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/266574
Acceso en línea:http://hdl.handle.net/10261/266574
Access Level:acceso abierto
Palabra clave:Hypoxia
PARP-1
PARylation
ChIP-seq
Tumor microenvironment
Descripción
Sumario:[Background] The adaptation to hypoxia is mainly controlled by the HIF transcription factors. Increased expression/activity of HIF-1α correlates with poor prognosis in cancer patients. PARP-1 inhibitors are used in the clinic to treat BRCAness breast/ovarian cancer and have been shown to regulate the hypoxic response; therefore, their use could be expanded.

Similares en LA Referencia